Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada
Crossref DOI link: https://doi.org/10.1186/1710-1492-10-23
Published Online: 2014-05-07
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gerth, William C
Betschel, Stephen D
Zbrozek, Arthur S
Article History
Received: 20 January 2014
Accepted: 21 April 2014
First Online: 7 May 2014